BioLineRx (BLRX) Inventory (2023 - 2025)

BioLineRx's Inventory history runs 3 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• In Q4 2025, Inventory fell 31.7% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (down 31.7% YoY), while the FY2025 annual figure was $2.1 million, down 31.7% from the prior year.
• Inventory was $2.1 million for Q4 2025 at BioLineRx, down from $2.2 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $3.6 million in Q2 2024 to a low of $1.4 million in Q3 2023.
• Historically, Inventory has averaged $2.7 million across 3 years, with a median of $2.9 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Inventory jumped 162.13% in 2024, then slumped 38.46% in 2025.
• A 3-year view of Inventory shows it stood at $2.0 million in 2023, then jumped by 61.03% to $3.1 million in 2024, then sank by 31.7% to $2.1 million in 2025.
• The last three Inventory figures came in at $2.1 million (Q4 2025), $2.2 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.